NanGenex, through its holding company, seeks to secure Alliances and Partnerships with pharmaceutical and biotech companies committed to incorporating the Super-API Technology option into their development programs. To achieve these objectives, DRGT Group will pursue Alliance and Partnership agreements with flexibility, believing that such agreements are best structured to meet the unique needs of the Alliance partner and NanGenex. NanGenex is “agnostic” as to agreement structure, as long as agreements are structured to facilitate the science and the deployment of the platform. Thus, agreements can range from the provision of all necessary Super-API service components applied to a compound of interest to the Partner, to the encompassing development collaboration deployed across the Partner’s development portfolio.